www.fda.gov Open in urlscan Pro
2a02:26f0:fb:593::2e60  Public Scan

Submitted URL: http://www.fda.gov/novelcoronavirus
Effective URL: https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-20...
Submission: On February 10 via api from US — Scanned from DE

Form analysis 2 forms found in the DOM

Name: searchFormGET https://search.usa.gov/search

<form class="fda-masthead__search sr-only" role="search" action="https://search.usa.gov/search" method="GET" name="searchForm" id="search-form" accept-charset="UTF-8">
  <div class="search-popover" id="search-popover">
    <div class="input-group pull-right" id="search-group">
      <label class="sr-only" for="search-query">Search FDA</label>
      <input accesskey="4" class="form-control search-input" id="search-query" name="query" aria-autocomplete="list" aria-haspopup="true" title="Enter the terms you wish to search for." placeholder="Search FDA" type="text">
      <span class="input-group-btn" id="input-group-btn">
        <button type="submit" class="btn btn-danger search-btn" id="search-btn" title="Search"><span class="fa fa-search" aria-hidden="true"><span class="sr-only">Submit search</span></span></button>
      </span>
    </div>
  </div>
  <input name="affiliate" value="fda1" type="hidden">
</form>

POST https://public.govdelivery.com/accounts/USFDA/subscribers/qualify

<form class="form-horizontal" id="GD-snippet-form" action="https://public.govdelivery.com/accounts/USFDA/subscribers/qualify" accept-charset="UTF-8" method="post">
  <input name="utf8" type="hidden" value="✓">
  <input type="hidden" name="authenticity_token" value="VJuyc1HyD63+xVCkN+K9qiH1bD9zSSJ+BfdR1d4LXjZ0BncrJ/u9dEw/e0U869OeCw6JxhyYXfnZCCGNF1oVkQ==">
  <input type="hidden" name="topic_id" id="topic_id" value="USFDA_135">
  <label class="sr-only" for="email">Enter your email address to subscribe:</label>
  <div class="input-group subscribe-group">
    <input type="email" name="email" id="email" placeholder="Email Address" class="form-control">
    <span class="input-group-btn"><input class="btn btn-primary" type="submit" name="commit" value="Subscribe"></span>
  </div>
</form>

Text Content

 * Skip to main content
 * Skip to FDA Search
 * Skip to in this section menu
 * Skip to footer links

An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive
information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that
any information you provide is encrypted and transmitted securely.


U.S. FOOD AND DRUG ADMINISTRATION

 *   Search
 *   Menu

Search FDA Submit search


FEATURED

 * Contact FDA
 * FDA Guidance Documents
 * Recalls, Market Withdrawals and Safety Alerts
 * Press Announcements
 * Warning Letters
 * Advisory Committees
 * En Español


PRODUCTS

 * Food
 * Drugs
 * Medical Devices
 * Radiation-Emitting Products
 * Vaccines, Blood, and Biologics
 * Animal and Veterinary
 * Cosmetics
 * Tobacco Products


TOPICS

 * About FDA
 * Combination Products
 * Regulatory Information
 * Safety
 * Emergency Preparedness
 * International Programs
 * News and Events
 * Training and Continuing Education
 * Inspections and Compliance
 * Science and Research


INFORMATION FOR

 * Consumers
 * Patients
 * Industry
 * Health Professionals
 * Federal, State and Local Officials


In this section: Counterterrorism and Emerging Threats
 * Coronavirus Disease 2019 (COVID-19)
    * COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other
      Stakeholders
    * COVID-19 Frequently Asked Questions
    * COVID-19 Vaccines
    * Innovation to Respond to COVID-19
    * COVID-19 Educational Resources
    * COVID-19 Communication Toolkits
    * Multilingual COVID-19 Resources
   
   

 1. Home
 2. Emergency Preparedness and Response
 3. Counterterrorism and Emerging Threats
 4. Coronavirus Disease 2019 (COVID-19)

 1. Counterterrorism and Emerging Threats


CORONAVIRUS DISEASE 2019 (COVID-19)

Subscribe to Email Updates
 * Share
 * Tweet
 * Linkedin
 * Email
 * Print


Español
 


COVID-19 VACCINE BOOSTER INFORMATION AND ELIGIBILITY


ON THIS PAGE:

 * Latest COVID-19 News from FDA
 * Personal Protective Equipment
 * Emergency Use Authorizations and Guidances
 * Frequently Asked Questions
 * Popular Topics
 * FDA Response to COVID-19
 * COVID-19 Information About FDA Regulated Products
 * Contact FDA
 * Information from the Federal Government


COVID-19 VACCINES

 * Pfizer-BioNTech COVID-19 Vaccine & Comirnaty
 * Moderna COVID-19 Vaccine & Spikevax
 * Janssen COVID-19 Vaccine


COVID-19 FAQS

Frequently asked questions (FAQs) in English and Spanish.


RESOURCES FOR HEALTH PROFESSIONALS

Key resources for health professionals during the COVID-19 pandemic.


LATEST COVID-19 INFORMATION FROM THE FDA

Type of Information COVID-19 UpdateDaily RoundupPress Release / Public
StatementEventFDA Voices: Leadership PerspectivesSafety InformationConsumer
InformationPodcast / Video
Topic Animal & VeterinaryBiologicsDrugsFood & BeveragesGuidance
DocumentsImportsInspectionsMedical DevicesRecallsResearchTobacco ProductsWarning
Letters
Clear Filters
Search:
Show 102550100All entries
Export Excel

Date Update Type Topic 02/08/2022

FDA Roundup: February 8, 2022

The FDA issued a guidance for industry and investigators to announce a policy
discouraging sponsors from developing or seeking approval or authorization for
the use of sanitation tunnels, that spray humans with a mist of disinfectant or
aerosolized antiseptic with the aim of preventing or treating COVID-19. The
agency also warned health care providers, parents and caregivers of pediatric
patients (children) who receive enteral feeding that there is a risk of
strangulation from the use of enteral feeding delivery sets.

Press Release / Public Statement Drugs
Medical Devices 02/04/2022

FDA Roundup: February 4, 2022

The FDA determined that beginning on Feb. 7, the agency will resume conducting
domestic surveillance inspections across all commodities given the decline in
COVID-19 cases across the country. The FDA also issued a draft guidance advising
sponsors on the premarketing assessment of a drug’s effect on blood pressure.
Additionally, the FDA announced its 2022-2025 strategic priorities for the
Center for Devices and Radiological Health, a proposed rule to improve the
security of the drug supply chain as well as a new website showcasing the Center
for Veterinary Medicine’s innovative research to protect human and animal
health.

Press Release / Public Statement Drugs
Animal & Veterinary
Medical Devices 02/01/2022

Coronavirus (COVID-19) Update: FDA Advisory Committee Meeting to Discuss Request
for Authorization of Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months
Through 4 Years of Age

FDA announced a virtual meeting of its Vaccines and Related Biological Products
Advisory Committee on Feb. 15 to discuss the request for emergency use
authorization of the Pfizer-BioNTech COVID-19 Vaccine for use in children 6
months through 4 years of age.

Press Release / Public Statement Biologics

Showing 1 to 3 of 613 entries
 * Previous
 * 1
 * 2
 * 3
 * 4
 * 5
 * …
 * 205
 * Next


PERSONAL PROTECTIVE EQUIPMENT

Conservation strategies for PPE and other resources.

 * N95 respirators, surgical masks, and face masks
 * Medical gloves
 * Medical gowns
 * Medical glove conservation strategies
 * Surgical mask and gown conservation strategies


EMERGENCY USE AUTHORIZATIONS AND GUIDANCES


EMERGENCY USE AUTHORIZATIONS (EUAS)

Expedited authorization of medical products to address public health
emergencies.


GUIDANCE DOCUMENTS AND POLICIES

Policies and guidances to support rapid response to COVID-19.


FREQUENTLY ASKED QUESTIONS (FAQS)


ENGLISH

Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions


ESPAÑOL

Preguntas frecuentes sobre la Enfermedad del Coronavirus 2019 (COVID-19)


MORE FAQS ON SPECIFIC TOPICS

 * Hand sanitizer FAQs
 * FAQs on testing for SARS-CoV-2
 * 3D printing of medical devices & parts FAQs
 * Medical glove FAQs
 * Surgical mask & gown shortage FAQs
 * Face mask & surgical mask FAQs
 * Food industry FAQs
 * Ventilator FAQs
 * Animal food safety & COVID-19 industry FAQs
 * Manufacturing, supply chain, & drug inspections FAQs


POPULAR CORONAVIRUS TOPICS


COVID-19 TESTING


COVID-19 TREATMENTS


COVID-19 VACCINES


INFORMATION FOR PEOPLE WITH HEALTH CONDITIONS


FRAUDULENT PRODUCTS


FOOD SAFETY


INNOVATION


REMDESIVIR


HAND SANITIZER SAFETY

 


FDA RESPONSE TO COVID-19

How FDA facilitates development and availability of medical countermeasures to
combat COVID-19 with Medical Devices (PDF) and Therapeutics (PDF)


FDA 2021 YEAR IN REVIEW - WORKING FOR YOU (PDF)


CDER RESPONSE TO CORONAVIRUS (COVID-19): INFOGRAPHIC


FDA COVID-19 PANDEMIC RECOVERY AND PREPAREDNESS PLAN (PREPP) INITIATIVE


CDRH RESPONSE TO COVID-19 IN 2020


FDA RESPONSE: INFOGRAPHIC (PDF)


CORONAVIRUS TREATMENT ACCELERATION PROGRAM (CTAP)

 


COVID-19 INFORMATION ABOUT FDA REGULATED PRODUCTS

Learn more about how FDA is facilitating the development and availability of
medical countermeasures and protecting the public health.


FOOD


DRUGS


MEDICAL DEVICES


ANIMAL & VETERINARY


BIOLOGICS

 


CONTACT FDA


DIAGNOSTIC TEST DEVELOPERS

See FAQs on Diagnostic Testing for SARS-CoV-2. If you need additional
information about completing the EUA template, would like to know how to submit
your Pre-EUA/EUA submission to FDA, or wish to consider use of an alternative
specimen type, please contact the Division of Microbiology Devices at (301)
348-1778 or email CDRH-EUA-Templates@fda.hhs.gov.


VACCINE & BIOLOGIC DEVELOPERS

Contact Manufacturers Assistance and Technical Training Branch (MATTB). Email
industry.biologics@fda.hhs.gov or call 1-800-835-4709 for further information.


DRUG DEVELOPERS

For therapeutics sponsors interested in submitting drug development proposals
for review, see COVID-19 Therapeutics: General Information for Interested
Stakeholders. Email covid19-productdevelopment@fda.hhs.gov


PHYSICIANS SEEKING AN EMERGENCY IND

Please call 855-543-3784 if you are a physician who would like to request an
Emergency Investigational New Drug (EIND) application for antiviral products


PRESS / MEDIA

FDA’s Office of Media Affairs

 * Email fdaoma@fda.hhs.gov
 * Call 301-796-4540


ALL OTHER INQUIRIES

FDA’s main Contact Us page


REPORT A PROBLEM

 * Fraudulent Products (1-800-332-1088)
 * Shortages or Supply Issues
 * Import Problem


INFORMATION FROM THE FEDERAL GOVERNMENT


CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)

How to prepare and protect yourself, what to do if you’re sick, vaccines – and
more…


VACCINES.GOV

Find a COVID-19 vaccine near you, get the latest COVID-19 vaccine information,
and connect with the COVID-19 Vaccine Hotline


COVID-19 TREATMENT GUIDELINES

Evidence-based recommendations on the management of COVID-19 for health care
providers


USA.GOV/CORONAVIRUS

The federal government response to COVID-19, including stimulus payments


OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION

Information for workers and employers about COVID-19 from the U.S. Department of
Labor


FEDERAL EMERGENCY MANAGEMENT AGENCY (FEMA)

How FEMA is supporting COVID-19 vaccine distribution, COVID-19 rumor control,
and how you can help during the pandemic

 






   CONTENT CURRENT AS OF:
   
   02/08/2022


 * TOPIC(S)
   
    * Emergencies
   
   
   HEALTH TOPIC(S)
   
    * Infectious Disease
    * Coronavirus

 * Coronavirus Disease 2019 (COVID-19)
    * COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other
      Stakeholders
    * COVID-19 Frequently Asked Questions
    * COVID-19 Vaccines
    * Innovation to Respond to COVID-19
    * COVID-19 Educational Resources
    * COVID-19 Communication Toolkits
    * Multilingual COVID-19 Resources
   
   


SUBSCRIBE

Sign up to receive email alerts on emergency preparedness and response topics
from FDA, including medical countermeasures, COVID-19, and other emerging
infectious diseases.

Enter your email address to subscribe:



FOOTER LINKS

 * FDA Archive
 * About FDA
 * Accessibility

 * Visitor Information
 * Website Policies / Privacy
 * No FEAR Act

 * FOIA
 * HHS.gov
 * USA.gov

Contact FDA Follow FDA on Facebook Follow FDA on Twitter View FDA videos on
YouTube Subscribe to FDA RSS feeds
FDA Homepage
Contact Number 1-888-INFO-FDA (1-888-463-6332)

Back to Top